We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Lumateperone in the treatment of psychiatric disorders – a review of the literature
PeriodicalsMedical Sciences

Lumateperone in the treatment of psychiatric disorders – a review of the literature

Checking your access to this record.

Abstract & Overview

Drug Administration) for the treatment of patients with schizophrenia and depressive episodes associated with bipolar disorder in 2019.Literature review.The review includes up-to-date publications concerning the efficacy of lumateperone in the treatment of psychiatric disorders -schizophrenia, bipolar disorder, but also insomnia, and dementia.The pharmacokinetic and pharmacodynamic characteristics of lumateperone and its precise mechanism of action were presented.The adverse reactions and possible drug interactions were likewise discussed.Conclusions.Lumateperone is a medication with an interesting mechanism of action, which is unique compared to other antipsychotic drugs.The analysis of clinical trials suggests that lumateperone is an effective and safe medication for the treatment of schizophrenia, as well as bipolar affective disorder.There are high hopes for the use of lumateperone in the treatment of insomnia and dementia. StreSzczenieCel. Terapia schorzeń psychiatrycznych, w tym schizofrenii i choroby afektywnej dwubiegunowej, ciągle się zmienia.Pojawiają się nowe substancje, które sprawiają, że leczenie wiąże się z mniejszą liczbą działań niepożądanych i wykorzystuje nowe mechanizmy działania.Celem artykułu jest przedstawienie właściwości, mechanizmu działania, zastosowania, ale i bezpieczeństwa lumateperonu -leku zaliczanego do substancji o działaniu AbStrAct Objectives.The treatment of psychiatric disorders, including schizophrenia and bipolar disorder, is constantly changing.There are new medications that reduce treatment-related side effects and present new mechanisms of action.This article aims to describe characteristics, mechanism of action, and medical use, but also the safety of lumateperone -a drug classified as antipsychotic medication, which was approved by the FDA (Food and Review article / Artykuł poglądowy Lumateperone in the treatment of psychiatric disorders -a review of the literatureLumateperon w leczeniu schorzeń psychiatrycznych -przegląd literatury

Cite this record

Ada Kaczmarek, Wiktor Szymajda, Katarzyna Dettlaff (2023). Lumateperone in the treatment of psychiatric disorders – a review of the literature. Pharmacotherapy in Psychiatry and Neurology, 39(1), 39–52. https://doi.org/10.5114/fpn.2023.127423

Copy in another style

Kaczmarek, A., Szymajda, W., & Dettlaff, K. (2023). Lumateperone in the treatment of psychiatric disorders – a review of the literature. Pharmacotherapy in Psychiatry and Neurology, 39(1), 39–52. https://doi.org/10.5114/fpn.2023.127423
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.